Back to search results

The Efficacy of Camrelizumab Plus Stereotactic Body Radiotherapy in R/M NPC

Abroad (travel likely)RecruitingPHASE2

Conditions

Nasopharyngeal Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Chongqing University Cancer Hospital, Chongqing, Chongqing Municipality, China

    Contact: Study coordinator (Jiangdong Sui, Ph.D, M. D.) · jiangdong.sui@cqu.edu.cn · 13594910011
    Contact: Study coordinator (Ying Wang, Ph.D, M. D.) · yingwang197011@163.com · 13996412826
    Contact: Principal Investigator (Ying Wang, Ph.D, M. D.)
    Jiangdong Sui, Ph.D, M. D. (Sub-investigator)

  • Chongqing University Three Gorges Hospital, Wanzhou, Chongqing Municipality, China

    Contact: Study coordinator (Chuan Zhu, M.D) · 981149098@qq.com · 13983505825

  • The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China

    Contact: Study coordinator (Kun He) · xnydhh@163.com · 0830-3165273
Study leads

  • Ying Wang, Ph.D, M.D.

    Principal Investigator

    Chongqing University Cancer Hospital

View source on ClinicalTrials.gov(opens in a new tab)